RxDoctor Payments Data

Rafael Rodighiero, PA

Medical · Chapmanville, WVNPI 1881969475

Payments from drug & device makers

$1,033in general payments, 2019–2025

Across 78 payments — averaging $13.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$428
  • AbbVie$184
  • Biohaven Pharmaceuticals, Inc.$123
  • Biohaven Pharmaceutical Holding Company Ltd.$60
  • Eisai Inc.$57
  • Almatica Pharma LLC$45
  • plus $136 from 7 others

What the payments were for

  • Food & beverage$1,033100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,033 in reported general payments places this provider in the 55th percentile of 233 medical providers in West Virginia.

See all medical providers in West Virginia

Medicare billing

Part B allowed, 2024
$49,631
Medicare patients
119
Services billed
671

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide91$116,880
TrulicityDulaglutide34$67,346
EliquisApixaban89$58,329
JardianceEmpagliflozin48$49,177
MounjaroTirzepatide16$35,937
JanuviaSitagliptin Phosphate22$28,632
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$27,475
TradjentaLinagliptin25$18,661
LinzessLinaclotide19$16,649
XareltoRivaroxaban22$16,527
Lantus SolostarInsulin Glargine,hum.Rec.Anlog74$9,649
EntrestoSacubitril/Valsartan11$8,307
SymbicortBudesonide/Formoterol Fumarate21$6,882
Albuterol Sulfate HfaAlbuterol Sulfate157$5,952
Omeprazole400$2,987

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$13$116,88091 claims
Lilly USA, LLCTrulicity, Mounjaro$25$103,28350 claims
Boehringer IngelheimJardiance, Tradjenta$12$67,83873 claims
PfizerEliquis$428$58,32989 claims
AbbVieLinzess, Synthroid$184$18,64149 claims
AstraZenecaSymbicort$29$6,88221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 233 medical providers in West Virginia.

Other medical in Chapmanville

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →